Is It Possible for One Partner to Have Chlamydia and Not the Other?

One partner testing positive for chlamydia while the other tests negative is not only possible, it is surprisingly common. Studies of couples screened together consistently find that discordant results, where only one partner carries the infection, occur more often than concordant positives. The reasons range from incomplete transmission to spontaneous clearance to tests that miss infections hiding outside the genital tract. Understanding why this happens can save a relationship from unnecessary suspicion and, more practically, keep both partners from getting reinfected.

Chlamydia Does Not Spread Every Time

The single biggest reason one partner can have chlamydia and the other can avoid it is that the bacteria do not transmit with every sexual encounter or even every partnership. A large evidence synthesis drawing on national probability surveys estimated that the chance of transmission from an infected man to a female partner over the course of a partnership sits at roughly one in three. In the other direction, female-to-male transmission was estimated to be lower, though the range of uncertainty was wide, from around 5 percent to as high as 21 percent depending on the dataset used.¹ Those numbers are per partnership, not per act of intercourse, and they account for couples who may have had sex many times. Transmission is far from automatic.

Because no study can ethically control who is sleeping with whom and how often, researchers acknowledge an inherent limitation: in cross-sectional studies of couples, you cannot tell which direction transmission went or how likely it was on any single occasion.² Still, the consistent finding across different research designs is that plenty of sexual partnerships involve only one infected person throughout their duration.

What Couple-Level Screening Actually Finds

When researchers screen both members of a couple at the same time, the results often look lopsided. In one large screening study of asymptomatic couples, both partners tested positive in only about a third of the couples where at least one partner had chlamydia. Out of 78 couples with at least one positive test, just 27 had matching positive results.³ A separate study using PCR-based testing found a concordant infection rate of 33 percent and estimated that screening only one partner could miss over half of the infected couples entirely.⁴

Concordance rates do rise when the infected partner has a heavier bacterial load. A genotype-concordance study found that about 73 percent of male partners of women who tested positive on a highly sensitive lab test were also infected, but among partners of women who tested positive on a less sensitive assay (suggesting a lower bacterial burden), concordance dropped to roughly a third.⁵ In practical terms, a partner who has recently acquired the infection and is shedding large amounts of bacteria is more likely to pass it along. Someone whose infection is winding down may not transmit it at all.

The Body Can Clear Chlamydia on Its Own

Another explanation for discordant results is that one partner may have been infected at some point but cleared the bacteria without treatment. Chlamydia is not necessarily a lifelong infection the way some viral STIs can be. In a five-year follow-up study of women with confirmed chlamydia who received no specific antibiotic treatment, 94 percent had cleared their infections by the four-year mark.⁶ A shorter follow-up study found that about 45 percent of asymptomatic infections cleared within a single year, and none of the women in that study developed pelvic inflammatory disease during the observation period.⁷

Clearance can happen quickly for some people. A screening study in China found that about 24 percent of infected women spontaneously cleared the bacteria within a median of 27 days.⁸ So it is entirely plausible that both partners were infected months ago, one cleared it naturally, and the other still carries it when testing happens. The immune system’s ability to fight off the bacteria varies from person to person, which introduces another layer of mismatch between partners.

That said, banking on spontaneous clearance is risky. While the body does clear many infections eventually, untreated chlamydia can persist for months or years, and the longer it lingers, the more damage it can do to the reproductive tract. One study following women with recurrent same-strain infections found evidence that certain strains can persist cervically for years, with many “negative” tests in between that turned out to still harbor bacterial DNA when retested with more sensitive methods.⁹ The safe move remains getting treated promptly.

A Negative Test Does Not Always Mean No Infection

Modern chlamydia tests are good, but they are not perfect, and the way samples are collected matters. For women, vaginal swabs tend to outperform urine samples. A meta-analysis found that vaginal swabs picked up about 94 percent of chlamydia infections compared to about 87 percent for urine.¹⁰ That gap might seem small in percentage terms, but it means that for every hundred infected women tested with urine, roughly thirteen will get a falsely reassuring negative result.

The specific test platform also plays a role. In one head-to-head comparison of three lab methods applied to the same self-collected vaginal swabs, two of the assays caught 100 percent of chlamydia cases, while the third missed about 18 percent.¹¹ When self-collected vaginal swabs were compared to clinician-collected cervical swabs across several studies, the pooled sensitivity was around 85 to 92 percent, depending on the analysis.¹² Self-collection is still a good option and makes screening more accessible, but it is not infallible.

Infections Outside the Genital Tract Can Hide

Standard chlamydia screening typically tests a genital sample: a urine cup or a vaginal or urethral swab. But chlamydia can live in the rectum and the throat, and those sites are often not tested unless a patient specifically asks or discloses relevant sexual practices. This creates a blind spot. A large analysis found that among men with rectal chlamydia infections, 86 percent had a negative genital test. Among those with pharyngeal chlamydia, about 90 percent tested negative at the genital site.¹³

Women are affected by this testing gap as well. In one clinic-based study, nearly half of women with a positive rectal or pharyngeal chlamydia test would have been missed entirely if only genital testing had been performed.¹⁴ So when one partner tests positive and the other tests negative based on a genital-only screen, it is worth considering whether the “negative” partner might simply be harboring the infection somewhere else. Oral sex, though generally considered lower risk for chlamydia transmission than penetrative sex, can still lead to pharyngeal colonization.¹⁵

Why Some People Are Harder to Infect

Even when two people share the same exposure, their bodies may respond differently. The vaginal microbiome appears to play a genuine role in susceptibility to chlamydia. Women whose vaginal bacteria are dominated by certain Lactobacillus species seem to have a degree of natural protection against chlamydia acquisition, while women with a disrupted microbiome, particularly an overgrowth of anaerobic bacteria, face a higher risk of both catching and failing to clear the infection.¹⁶ The metabolites produced by these bacterial communities, including fatty acids and compounds that compete for resources the pathogen needs, can either help or hinder the bacteria’s ability to take hold.¹⁷

For men, anatomical factors can matter. A national probability survey in Britain found that circumcised men had markedly lower odds of testing positive for chlamydia compared to uncircumcised men, even after adjusting for differences in sexual behavior and demographics.¹⁸ The inner foreskin has a high density of target cells that chlamydia can infect, and removing that tissue may reduce the physical surface area where the bacteria can establish themselves. This is one factor among many, and it does not make circumcised men immune, but it does help explain why the same exposure can produce different outcomes in two individuals.

Not All Chlamydia Strains Behave the Same Way

Chlamydia is not a single uniform organism. It comes in multiple strains, and research in animal models suggests they differ meaningfully in how readily they infect and how long they persist. In one mouse study, two strains caused weeks of active shedding and fertility rates below 25 percent, while two other strains produced almost no detectable shedding and left fertility largely intact.¹⁹ Lab studies have also shown that different strains attach to epithelial cells through different mechanisms, with some invading tissue more aggressively than others.²⁰

What this means in human terms is still being worked out, but the implication is that the particular strain circulating in a partnership affects how easily it transmits. A highly infectious strain carried at a high bacterial load is a different proposition than a less aggressive strain at low levels. This biological variability stacks on top of all the host and behavioral factors already discussed, further explaining why discordant results are the norm rather than the exception in couple-level screening.

The Ping-Pong Problem and Why Both Partners Need Treatment

When one partner is diagnosed, the immediate practical question is what to do about the other one, even if they have tested negative. Standard clinical guidance recommends treating both partners simultaneously to avoid what clinicians sometimes call ping-pong reinfection: one person gets treated, has sex with their still-infected partner, and ends up right back where they started. A cohort study of young women in England found that the two strongest predictors of getting chlamydia again after treatment were acquiring new sexual partners and failing to treat all existing partners.²¹

The reinfection rate after treatment is not trivial. In one randomized trial exploring different strategies for reaching partners, 15 percent of treated women tested positive again within 12 months.²² This is why guidelines recommend retesting a few months after treatment. The retest is not checking whether the antibiotic worked (it almost always does); it is checking whether the person has been reinfected by an untreated partner or a new contact.

Getting Treatment to Partners Who Will Not Come In

One of the biggest real-world obstacles is that partners often do not show up to a clinic. They may not have symptoms, may not believe the diagnosis, or may face logistical barriers like cost or time. Expedited partner therapy addresses this by allowing the diagnosed patient to deliver antibiotics directly to their partner without the partner needing a separate clinic visit. The CDC recommended this approach beginning in 2006, and over 30 states now permit it for chlamydia, gonorrhea, or both.²³

Evidence from randomized trials and program evaluations generally shows that expedited partner therapy increases the proportion of partners who actually take the medication. Whether it consistently reduces reinfection rates in the diagnosed patient is less clear. Some studies show a benefit; others do not. A community-level trial in Washington State found that scaling up expedited partner therapy across an entire region led to a modest decrease in population-level chlamydia and gonorrhea rates in women, though the researchers described the evidence as suggestive rather than definitive.²⁴ Even with imperfect evidence for population-level impact, treating the partner who will not come in is better than leaving them untreated and hoping for the best.

When Discordant Results Strain a Relationship

A positive chlamydia test in a monogamous relationship almost inevitably raises questions about fidelity, but the biology is more forgiving of innocent explanations than most people realize. The infection can be carried asymptomatically for months and in some documented cases for years. A person could have acquired chlamydia from a previous partner long before the current relationship began, never noticed symptoms, and only tested positive at a routine screen. Their current partner, exposed to the same bacteria, may have cleared it spontaneously or may never have picked it up at all, given the per-partnership transmission probabilities discussed earlier.

None of this proves that infidelity did not occur, but it does mean that a discordant chlamydia result is not reliable evidence that it did. Clinicians who counsel couples in this situation generally emphasize the long asymptomatic window and the incomplete transmission rate as genuine, well-documented explanations for one-partner-positive results. From a health standpoint, the most productive response is to treat both partners, retest in three months, and address the relationship dynamics separately from the medical ones.